MFS
HRTX icon

MSI Financial Services’s Heron Therapeutics HRTX Stock Holding History

MSI Financial Services’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$20K Hold
1,500
– – ﹤0.01% 2391
2016
Q3 		$26K Buy
1,500
+1,000
+200% +$18.6K ﹤0.01% 2210
2016
Q2 		$9K Hold
500
– – ﹤0.01% 2827
2016
Q1 		$9K Hold
500
– – ﹤0.01% 2831
2015
Q4 		$13K Buy
+500
New +$13.4K ﹤0.01% 2557

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM

MSI Financial Services's HRTX Position: Q4 2016 in Review

MSI Financial Services held its Heron Therapeutics (HRTX) position steady in Q4 2016 at 1,500 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #2391.

MSI Financial Services first reported a position in HRTX in Q4 2015 and has held it in 5 quarters since. The position peaked at $26K in Q3 2016. 99 funds tracked by Wall St. Rank hold HRTX as of Q4 2016.

  • MSI Financial Services held 1,500 shares of Heron Therapeutics worth $20K as of Q4 2016.
  • MSI Financial Services left its Heron Therapeutics share count unchanged in Q4 2016.
  • Heron Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2391 holding.
  • MSI Financial Services first reported a position in Heron Therapeutics in Q4 2015 and has held it in 5 quarters since.
  • MSI Financial Services's Heron Therapeutics position peaked at $26K in Q3 2016.
  • 99 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.